Who
Douglas E. Giordano
Director
Company insider
Files Form 4 as: Director, Kardigan; Director, Cerevel Therapeutics Holdings; Director, Zoetis.
In numbers
- Trades disclosed
- 11
- Buys
- 1
- Sells
- 0
- Bought
- $130K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 6 Feb 2013
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 1 Aug 2024filed 5 Aug 2024 | Cerevel Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —95,242 | filing |
| 1 Aug 2024filed 5 Aug 2024 | Cerevel Therapeutics Holdings | SEC FORM 4 Code D | —3,282 | filing |
| 1 Aug 2024filed 5 Aug 2024 | Cerevel Therapeutics Holdings | SEC FORM 4 Code D | —10,461 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Cerevel Therapeutics Holdings | SEC FORM 4 Code A | —10,461 | filing |
| 7 Jun 2023filed 9 Jun 2023 | Cerevel Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —13,780 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | Cerevel Therapeutics Holdings | SEC FORM 4 Code A | —3,282 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Cerevel Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —23,459 at $0.00 | filing |
| 10 Jun 2021filed 14 Jun 2021 | Cerevel Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —58,003 at $0.00 | filing |
| 6 Feb 2013filed 8 Feb 2013 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Bought | $130K5,000 at $26.00 | filing |
News
ZTS - Zoetis Inc Class A AnalysisZTS · morningstar.com · 12 Oct 2026
0 headlines in the last 90 days name Douglas E. Giordano; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.